Stewart Kroll
About
In The Last Decade
Stewart Kroll
71 papers receiving 3.9k citations
Peers
Comparison fields: 5 of 104
- Radiology, Nuclear Medicine and Imaging 1.8k
- Pathology and Forensic Medicine 1.5k
- Oncology 1.3k
- Pulmonary and Respiratory Medicine 945
- Ophthalmology 905
Countries citing papers authored by Stewart Kroll
This map shows the geographic impact of Stewart Kroll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stewart Kroll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stewart Kroll more than expected).
Fields of papers citing papers by Stewart Kroll
This network shows the impact of papers produced by Stewart Kroll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stewart Kroll. The network helps show where Stewart Kroll may publish in the future.
Co-authorship network of co-authors of Stewart Kroll
This figure shows the co-authorship network connecting the top 25 collaborators of Stewart Kroll. A scholar is included among the top collaborators of Stewart Kroll based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stewart Kroll. Stewart Kroll is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 411 | |
| 3 | 12 | |
| 4 | 9 | |
| 5 | Re-treatment with Tositumomab and Iodine I 131 Tositumomab in patients with non-Hodgkin lymphoma who had previously responded to Tositumomab and Iodine I 131 Tositumomab | 2 |
| 6 | 494 | |
| 7 | 3 | |
| 8 | 40 | |
| 9 | 22 | |
| 10 | 46 | |
| 11 | Patient-specific whole-body dosimetry: principles and a simplified method for clinical implementation. | 94 |
| 12 | 66 | |
| 13 | 45 | |
| 14 | 7 | |
| 15 | 67 | |
| 16 | 157 | |
| 17 | 3 | |
| 18 | 11 | |
| 19 | 39 | |
| 20 | 26 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.